No Data
Kyorin Pharmaceutical To Go Ex-Dividend On March 30th, 2026 With 37 JPY Dividend Per Share
May 13th (Japan Standard Time) - $Kyorin Pharmaceutical(4569.JP)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 37 JPY dividend per share. The ex-
Kyorin Pharmaceutical To Go Ex-Dividend On September 29th, 2025 With 20 JPY Dividend Per Share
May 13th (Japan Standard Time) - $Kyorin Pharmaceutical(4569.JP)$ is trading ex-dividend on September 29th, 2025.Shareholders of record on September 30th, 2025 will receive 20 JPY dividend per share.
MITSUBISHI ESTATE, operating profit for the year ending March 25 increased by 11.0%, reaching 309.2 billion yen, and Financial Estimates for the year ending March 26 predict a 5.1% increase to 325 billion yen.
MITSUBISHI ESTATE <8802> announced its performance for the fiscal year ending March 2025, with operating revenue increasing by 5% year-on-year to 1 trillion 579.8 billion 12 million yen and operating profit rising by 11% to 309.2 billion 32 million yen. In the commercial real estate business, revenues increased for office buildings, commercial facilities, outlet malls, hotels, and real estate sales. For the fiscal year ending March 2026, operating revenue is projected to increase by 17.1% year-on-year to 1 trillion 850 billion yen, and operating profit is expected to rise by 5.1% to 325 billion yen. [Positive evaluation]
KYORIN Pharmaceutical Announces Executive Personnel Changes
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
